Sign Up Today and Learn More About Adimab Stock
Invest in or calculate the value of your shares in Adimab or other pre-IPO companies through EquityZen's platform.
Adimab Stock (ADIM)
Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.
About Adimab Stock
Founded
2007
Headquarters
Lebanon, NH, US
Total Funding
45.3M
Industries
Software, Artificial Intelligence, Data and Analytics
Adimab Press Mentions
Stay in the know about the latest news on Adimab
Adimab Collaborator GSK Receives Additional Marketing Approval for Depemokimab
morningstar • Apr 15, 2026
SK bioscience In-Licenses RSV Preventive mAb Candidate from Gates Medical Research Institute
prnewswire • Feb 03, 2026
Adimab Records Another Year of Double-Digit Clinical Program Growth
morningstar • Jan 15, 2026
Adimab Records Another Year of Double-Digit Clinical Program Growth
prnewswire • Jan 15, 2026
Adimab Reports Strong Partnering Year for 2025
morningstar • Jan 13, 2026
Adimab Management
Leadership team at Adimab
General Counsel
Philip Chase
Advisor
Colin Greenspon
Join now and verify your accreditation status to gain access to:
- Adimab Current Valuation
- Adimab Stock Price
- Adimab Management
- Available deals in Adimab and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Adimab Cap Table and Funding History by Share Class and Liquidity Preferences
- Adimab Revenue and Financials
- Adimab Highlights
- Adimab Business Model
- Adimab Risk Factors
- Adimab Research Report from SACRA Research
Trading Adimab Stock
How to invest in Adimab stock?
Accredited investors can buy pre-IPO stock in companies like Adimab through EquityZen funds. These investments are made available by existing Adimab shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Adimab stock?
Shareholders can sell their Adimab stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
